Welcome to our dedicated page for Dolby Laboratories SEC filings (Ticker: DLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Dolby Laboratories, Inc. (NYSE: DLB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual reports, quarterly updates, proxy materials, and current reports on material events. As a Delaware corporation with Class A common stock listed on the New York Stock Exchange, Dolby files documents such as Form 10-K, Form 10-Q, Form 8-K, and the Definitive Proxy Statement (DEF 14A) with the U.S. Securities and Exchange Commission.
Dolby’s filings offer detailed insight into its licensing-focused business model, which centers on technologies like Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and related audio and imaging intellectual property. In its proxy statement and other filings, the company discusses its single reportable segment, the importance of royalty-based revenue, and the role of cinema hardware and premium cinema technologies in its overall revenue mix.
Through current reports on Form 8-K, Dolby discloses financial results, dividends, and executive compensation plans. These filings cover quarterly and annual revenue, net income, non-GAAP metrics, and capital return actions such as cash dividends on Class A and Class B common stock. They also describe executive bonus plans that tie incentive payouts to non-GAAP operating income, revenue, and other performance metrics.
The Definitive Proxy Statement (DEF 14A) provides information on corporate governance and executive compensation, including proposals for the election of directors, advisory votes on named executive officer compensation, and ratification of the independent registered public accounting firm. It also summarizes non-GAAP financial measures and includes reconciliations to GAAP in appendices.
On Stock Titan, these filings are complemented by AI-powered summaries that help explain complex sections, highlight key figures and themes, and make it easier to understand Dolby’s financial condition, risk disclosures, and governance practices. Investors can use this page to follow Dolby’s official communications to regulators, monitor dividend and capital allocation decisions, and review the frameworks used to evaluate and reward the company’s leadership.
Dolby Laboratories insider John Couling has filed to sell additional common shares under Rule 144. The notice covers 6,667 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026, with an aggregate market value of 432,588.30. The filing notes 60,884,768 common shares outstanding and lists the NYSE as the trading venue.
The shares to be sold were originally acquired from the issuer as restricted stock and performance shares on various grant dates between 12/15/2020 and 12/15/2023. Over the past three months, Couling previously sold 7,273 common shares on 12/11/2025 for gross proceeds of 500,018.75 and 6,164 common shares on 11/20/2025 for gross proceeds of 407,563.68.
Dolby Laboratories reported net income attributable to the company of $53.3 million for the fiscal quarter ended December 26, 2025, on revenue of $346.7 million, down modestly from $357.0 million a year earlier. Licensing remained the core driver, contributing $319.8 million, or 92% of total revenue.
Net income declined from $67.8 million as operating income fell to $62.2 million, partly reflecting higher restructuring charges of $10.5 million. Dolby generated $54.8 million in operating cash flow and ended the quarter with $643.8 million in cash and cash equivalents plus $83.7 million in restricted cash, after repurchasing $70.0 million of stock and paying $34.3 million in dividends.
Dolby Laboratories, Inc. reported that it has released its financial results for the fiscal quarter ended December 26, 2025 through a press release furnished as an exhibit. The filing itself does not detail the numbers but points readers to the accompanying press release for full results.
The company also declared a cash dividend of $0.36 per share on its Class A and Class B common stock, payable on February 18, 2026 to stockholders of record as of the close of business on February 10, 2026. Dolby reiterates that it shares important information through its websites, SEC filings, press releases, and public calls.
Dolby Laboratories senior executive John Couling reported multiple equity awards and related share transactions in Class A common stock. On December 15, 2025, he received 25,633 restricted stock units under the 2020 Stock Plan, 12,816 performance-based restricted stock units, and an option to buy 56,440 shares at $66.62 per share.
The new PSU award has a three-year performance period from December 15, 2025 to December 12, 2028, with a potential payout from 0% to 200% of the 12,816-share target based on total shareholder return versus the S&P Mid Cap 400 Index and service-based vesting. A prior PSU grant with a 2022–2025 performance period vested at 64.65% of its 10,557-share target, resulting in 6,825 shares issued and 3,732 units cancelled. Shares worth 8,203 and 2,612 were withheld at prices of $67.54 and $66.62 to cover taxes, leaving 129,708 directly held Class A shares after the reported transactions, including 55,114 shares underlying unvested restricted stock units that are subject to forfeiture.
Dolby Laboratories executive Ryan Nicholson reported new equity awards and related share-withholding transactions. On December 15, 2025, he received an award of 9,032 restricted stock units under the company’s 2020 Stock Plan at a stated price of $0. One quarter of these units will vest on each anniversary of December 15, 2025, with each unit converting into one share of Class A common stock when it vests.
Also on December 15, 2025 and December 16, 2025, the company withheld 1,535 and 649 shares, respectively, at prices of $67.54 and $66.62 to cover taxes due upon vesting, in transactions exempt under Rule 16b-3. After these moves, Nicholson directly holds 36,956 Class A shares, including 19,303 shares underlying restricted stock units that remain subject to forfeiture until they vest.
Dolby Laboratories, Inc. executive Todd Pendleton, SVP and Chief Marketing Officer, reported new equity awards and related share movements. On 12/15/2025 he received 18,848 restricted stock units, 9,424 performance-based restricted stock units, and options for 41,500 shares of Class A common stock at $66.62, all subject to multi-year vesting conditions.
On the same dates, 5,233 performance-based units from a prior award vested after a three-year performance period, while Dolby withheld 6,056 shares at $67.54 and 1,959 shares at $66.62 to cover taxes tied to vesting. After these transactions he beneficially owned 53,356 Class A shares, and shares held included 41,480 shares underlying restricted stock units that remain subject to forfeiture until they vest.
Dolby Laboratories president and CEO Kevin Yeaman reported multiple equity transactions in December 2025. On December 15 he received 65,968 restricted stock units and a new performance-based restricted stock unit award covering 32,984 shares, plus an option to buy 145,252 shares of Class A common stock at $66.62 per share, all under Dolby’s 2020 Stock Plan. A prior performance-based award from 2022 vested at 64.65% of its 27,273-share target, delivering 17,633 shares while 9,640 units were cancelled, and Dolby withheld 27,180 and 6,855 shares to cover associated taxes. On December 16 and 17, a family trust for Yeaman sold several blocks of Dolby stock at weighted average prices including $66.6404 and $67.2351 per share under a Rule 10b5-1 trading plan adopted on February 28, 2025, and continues to hold Dolby shares on his behalf.
Dolby Laboratories senior vice president Shriram Revankar reported several equity compensation transactions. On December 15, 2025, he received 22,617 restricted stock units that vest in four annual installments starting December 15, 2025, and a new performance-based award covering 11,308 stock units tied to a three-year total shareholder return measure versus the S&P Mid Cap 400 Index.
He was also granted an employee stock option for 49,800 shares of Class A common stock at an exercise price of $66.62, vesting 25% after one year and monthly over the next 36 months until December 15, 2035. A prior performance-based award paid out at 64.65% of its 5,278-share target, so 3,412 units vested and 1,866 were cancelled, with shares withheld at $67.54 and $66.62 to cover taxes. After these transactions, he beneficially owns 86,218 Class A shares, including a large portion underlying unvested restricted stock units.
Dolby Laboratories executive Mark Andrew Sherman reported equity grants and share transactions in Class A common stock. On December 15, 2025 he received 25,633 restricted stock units that vest in four annual installments starting December 15, 2025, a performance-based restricted stock unit award for 12,816 target shares, and a stock option covering 56,440 shares at an exercise price of
Performance-based units originally granted in 2022 paid out at
Dolby Laboratories chief financial officer Robert Park reported new equity awards and related share movements in the company’s Class A common stock. On December 15, 2025 he received 23,371 restricted stock units under the 2020 Stock Plan, 11,685 performance-based restricted stock units tied to three-year total shareholder return, and 51,460 stock options exercisable at $66.62 per share.
A prior performance-based award with a target of 8,797 shares vested at 64.65% of target, resulting in 5,687 PSUs vesting and 3,110 being cancelled. Shares reported with transaction code F, totaling 6,473 and 2,285, were withheld to cover taxes on vesting. After these transactions, Park beneficially owns 86,385 Class A shares, including 48,874 shares underlying unvested restricted stock units that remain subject to future vesting.
FAQ
What is the current stock price of Dolby Laboratories (DLB)?
What is the market cap of Dolby Laboratories (DLB)?
